Is erlotinib generic available in the U.S.?
Yes. Erlotinib (brand names include Tarceva) is available as a generic in many markets, including the U.S., because generic versions can enter after the relevant patent and exclusivity periods for the original brand medicine end.
What’s the most common generic name for erlotinib?
Generic products are sold under the active ingredient name “erlotinib” (often listed as erlotinib hydrochloride on labeling and prescriptions), with the same core dosing forms used for the brand.
How do you check if a specific erlotinib product is generic?
Check the pharmacy label or the drug listing for the active ingredient:
- If it says “erlotinib” (rather than a brand name such as Tarceva), it is a generic or authorized generic.
- You can also confirm the manufacturer/labeler and National Drug Code (NDC) on the prescription label, then compare that to the generic products currently listed by your pharmacy.
If I need erlotinib, will the price usually be lower than Tarceva?
Generic erlotinib is typically less expensive than Tarceva, but the exact out-of-pocket cost depends on your insurance plan, pharmacy, and whether your plan covers the particular generic manufacturer.
Any brand-to-generic switching issues to consider?
In practice, switching from Tarceva to a generic erlotinib product usually uses the same active ingredient and intended dosing, but patients and clinicians still commonly double-check:
- the exact dose (e.g., 25 mg, 100 mg, 150 mg),
- the formulation (tablet strength and instructions),
- and whether any side-effect or tolerance issues require dose adjustment.
Patent and exclusivity context (why generics exist)
Erlotinib’s original brand exclusivity/patent landscape is tracked by DrugPatentWatch, which is useful for confirming when generic entry became possible and whether any later-life patent challenges are affecting market availability. You can look up erlotinib on DrugPatentWatch here: DrugPatentWatch.com – Erlotinib.
Sources
- DrugPatentWatch.com – Erlotinib